Andere talen Universal Ibogaine Inc.

Aandelen

IBO

CA91360F1099

Beurs gesloten - Toronto S.E. Andere beurzen 15:30:00 06-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,015 ^CAD	+50,00%		0,00%	+200,00%

22/04	Universal Ibogaine Inc. Kiest Ken Cranwill als raad van bestuur	CI
09/04	Ian Rabb niet langer werkzaam bij Universal Ibogaine als Chief Clinics Officer	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Universal Ibogaine announces closing of private placement financing	07/06
Universal Ibogaine Inc. cancelled the transaction announced on April 22, 2024	06/06
Universal Ibogaine Inc. announced that it has received CAD 0.27 million in funding	06/06
Universal Ibogaine provides update on planned Clinical Trial Application process	29/04
Universal Ibogaine Inc. Elects Ken Cranwill as Board of Director	22/04
Universal Ibogaine Announces Private Placement Financing and the Results of the Annual Meeting of Shareholders	22/04
Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding	22/04
Universal Ibogaine Announces New Private Placement Financing	15/04
Universal Ibogaine announces new private placement financing	12/04
Universal Ibogaine Inc. announced that it expects to receive CAD 0.6 million in funding	12/04
Universal Ibogaine announces closing of private placement financing	10/04
Universal Ibogaine Inc. announced that it has received CAD 0.575576 million in funding	10/04
Ian Rabb No Longer with Universal Ibogaine as Chief Clinics Officer	09/04
Universal Ibogaine advises of management change	09/04
Universal Ibogaine Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	29/03
Universal Ibogaine Announces Additional Private Placement Financing	22/02
Universal Ibogaine Inc. announced that it expects to receive CAD 0.8 million in funding	22/02
Universal Ibogaine Advises of Closing of Private Placement Financing	07/02
Universal Ibogaine Inc. announced that it has received CAD 0.417193 million in funding	07/02
Universal Ibogaine Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	05/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Universal Ibogaine Inc.

Aandelen

IBO

CA91360F1099

Andere talen

Filters